A Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers

Completed · Phase 1

Conditions studied: Smoking

In brief

Bioequivalence study to confirm that a NTS with a polyisobutylene (PIB) adhesive from an alternative supplier delivers the same nicotine blood profile as that of the currently approved NTS with a polyisobutylene adhesive from the current supplier.

Key facts

Study ID

NCT01702519

Run by

GlaxoSmithKline

People needed

40

Starts

2012-03-01

Expected to finish

2012-03-01

Last updated by the study team

2015-03-20

Who can join

Age: 19 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• BMI 19-27 kg/m2
• smokes >10 cigarettes per day for preceeding 6 months

You may not qualify if…

• inability to stop smoking during study

Where it is running

• Celerion NEBRASKA — Lincoln, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.